CYCC

Cyclacel Pharmaceuticals, Inc. CYCC

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode CYCC BOLT CAPR CLRB IMUC
6M -88.90 % -10.36 % -23.68 % -44.63 % -35.71 %
YTD -92.85 % -49.12 % -52.61 % -52.41 % -46.75 %
1Y -96.68 % -54.00 % -63.79 % -92.56 % -23.08 %
3Y -99.86 % -79.72 % 14.72 % -93.03 % -88.00 %
5Y -99.95 % -99.10 % 44.69 % -98.77 % -80.85 %
10Y -100.00 % -99.10 % -84.42 % -99.99 % -80.85 %
From the beginning -100.00 % -99.10 % -98.42 % -100.00 % -80.85 %

Dividend

Cyclacel Pharmaceuticals, Inc.

Bolt Biotherapeutics, Inc.